PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Lidocaine - Pain relief in Rib fracture

PAD Profile : Lidocaine - Pain relief in Rib fracture

Brand Names Include :
Versatis

Traffic Light Status

Status 1 of 1.

Status :
Red
Important
Formulations :
  • Medicated plaster
Important Information :
Off-label use. See narrative for details
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
R
U
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

No drugs returned.

Other Indications

Additional Documents

No additional documents returned.

Committee Recommendations

Date
Committee Name
Narrative
05 June 2024
SASH DTC

Indication:  Rib fracture (off-label). Approved for use on advice of pain team, ICU, anaesthetic, surgical, orthopaedic and ED consultants only

It is indicated in the following situations:

  1. First line for elderly patients (age >65) eg those with high risk systemic side-effects from opiates, dementia and delirium, falls causing chest trauma.
  2. First line for patients with a high chest injury score prior to waiting for regional infusion via CEPOD theatre if likelihood of delays.
  3. First line for patients not suitable for regional procedure eg dementia with aggression, anterior/ sternal fractures or high risk due to anticoagulation therapy.
  4. Second line for physically well patients whose pain is not well controlled with other analgesia.
  5. First line for patients where opioids are not appropriate or need to be reduced to reduce risk of respiratory depression and other side effects. 

Supply for maximum of 2 weeks 

Associated BNF Codes

15. Anaesthesia
15.02.01. Local anaesthetics
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More